Tagged with GI

Ireland Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key priorities of their exciting new Mercury 2021 strategy, the rationale behind their transition into a sector-based company rather than a geography-based one, their commitment to continuous improvement in terms of staff capabilities and technology,…

Ukraine Aleksandr Iavorskyi, founder and president of Biocon, Ukraine’s leading third-party logistics (3PL) company in the pharmaceutical and healthcare areas, provides insights into Biocon’s impressive development and unique partnership approach as well as the life-changing home delivery services that the company introduced into the Ukrainian market. He also documents the main…

Pharma PharmaBoardroom’s readers were polled on what they felt was the most disruptive force in the pharmaceutical industry today. Possible answers were big data and digitalization, patient-centricity, economic austerity, and advancements in supply chain management. Big Data and Digitalization Overall, most respondents chose big data and digitalization (34 percent) and economic…

Algeria In June 2017, PharmaBoardroom hosted an exclusive round table discussion with key players in Algerian healthcare on the role of health economics and patient data in health policy decision making. The participants were Dr Djaouad Brahim Bourkaib, Director General of Social Security in the Ministry of Labor, Jean-Paul Digy, Vice President for…

Colombia Esteban Lizarazo, CEO of Amarey Group, one of the most vibrant Colombian success stories, shares his insights on the company’s aim to diversify, while introducing the group’s highly innovative business model consisting of world class logistics, high level education and development of close relationships with hospitals. Mr. Lizarazo having worked…

Colombia Francisco Ricaurte, Country Manager for global logistics provider UPS in Colombia, discusses the importance of the Colombian market for UPS’s regional business, while sharing insights on the company’s recently opened state-of-the-art healthcare facility.  Mr. Ricaurte, you have been working for UPS for 20 years, occupying the position of country manager…

Indonesia Honesti Basyir, president director at Kimia Farma, explains the transition towards digitalization in the healthcare industry and his plans to take Kimia Farma from the top six to the top three in the Indonesian pharmaceutical industry by 2019. Mr. Honesti, you were appointed president director of Kimia Farma in April…

Indonesia Jonathan Sudharta, member of the the Board of Directors at Mensa Group, shares insights on the vertical integration strategy of Mensa to offer an end-to-end solution as well as shows how the new investment in Halodoc – a disruptive healthcare mobile application – will help the group to be closer…

Indonesia Christian Eberle, president director at APL, explains the challenges and opportunities within the Indonesian healthcare distribution arena as well as the company’s strategy to bring more high-quality medicines to patients over the next two years. After over two years as CEO of APL, could you provide us with an overview…

Colombia Mariella Soto, QuintilesIMS’ country manager for Colombia, has been working in the pharmaceutical-related industry for over 25 years. She explains how her previous experience as a pharmaceutical executive is helping her to develop customer-focused services with QuintilesIMS and the company’s latest innovations in data mining and analysis. You have a…

Indonesia Djonny Hartono Tjahyadi, president director at Enseval, explains the challenges and opportunities within the Indonesian healthcare logistics and distribution arena and his vision to ensure that the company obtains a sustainable double-digit growth level. Can you briefly introduce Enseval’s main activities and responsibilities? “Enseval is the largest distributor in Indonesia…

Ukraine Tetyana Dumenko, director of the State Expert Center (SEC) of the Ministry of Health of Ukraine, the regulatory agency responsible for product registration, pre-clinical studies and clinical trials approval and pharmacovigilance, provides insights into some of her initial achievements since taking the position and her main strategic priorities to further…